Body composition in homozygous beta-thalassemia.
Kalef-Ezra
J
J
Department of Medical Physics, Medical School, University of Ioannina, Greece. jkalef@cc.uoi.gr
Zibis
A
A
Chaliassos
N
N
Hatzikonstantinou
I
I
Karantanas
A
A
D000293:Adolescent; D000328:Adult; D001803:Blood Transfusion; D001823:Body Composition; D015519:Bone Density; D002614:Chelating Agents / Q000627:therapeutic use; D003676:Deferoxamine / Q000627:therapeutic use; D005260:Female; D006720:Homozygote; D006801:Humans; D008297:Male; D009501:Neutron Activation Analysis; D011188:Potassium / Q000032:analysis; D017086:beta-Thalassemia / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy
D002614:Chelating Agents; D003676:Deferoxamine; D011188:Potassium